Evaluation of the Usability and Pharmaeconomy of the MicroTech Insulin Pump System

Evaluation of the Usability and Pharmaeconomy of the MicroTech Insulin Pump System - MIC-CSII-001

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033431

Enrollment

120

Registered

2024-01-18

Start date

2023-11-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 1 and 2

Interventions

Group 1: adult subjects with type 1 or type 2 diabetes on intensive insulin treatment with insulin pumps Group 2: adult subjects with type 1 or type 2 diabetes on intensive insulin treatment with mult

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients on insulin pump treatment (CSII, 100 patients) Patients on insulin treatment (20 patients, Germany only) HbA1c < 9.0 % Subjects who are able to complete informed consent form (by him-/herself or by his/her guardian)

Exclusion criteria

Exclusion criteria: Hypoglycemia unawareness Pregnancy Nursing mothers Any reason for not being able to comply with the protocol. Serious disease or illness

Design outcomes

Primary

Measure	Time frame
Treatment efficacy (HbA1c and hypoglycemia frequency)	—

Secondary

Measure	Time frame
Pharmacoeconomic aspects (treatment costs) Safety aspects (AEs and ADEs) Environmental aspects (waste reduction)	—

Countries

Germany

Contacts

Public ContactAndreas Pfützner

PSHI Praxis GmbH

info@pfuetzner-mainz.com06131 5884640

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026